skip to main content
Idioma:
Refinado por: autor: Tebaldi, Matteo remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Prasugrel Versus Tirofiban Bolus With or Without Short Post-Bolus Infusion With or Without Concomitant Prasugrel Administration in Patients With Myocardial Infarction Undergoing Coronary Stenting
Prasugrel Versus Tirofiban Bolus With or Without Short Post-Bolus Infusion With or Without Concomitant Prasugrel Administration in Patients With Myocardial Infarction Undergoing Coronary Stenting
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prasugrel Versus Tirofiban Bolus With or Without Short Post-Bolus Infusion With or Without Concomitant Prasugrel Administration in Patients With Myocardial Infarction Undergoing Coronary Stenting

Valgimigli, Marco, MD, PhD ; Tebaldi, Matteo, MD ; Campo, Gianluca, MD ; Gambetti, Stefania, BSc ; Bristot, Laura, BSc ; Monti, Monia, BSc ; Parrinello, Giovanni, PhD ; Ferrari, Roberto, MD, PhD

JACC. Cardiovascular interventions, 2012-03, Vol.5 (3), p.268-277 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
2
Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial
Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial

Valgimigli, Marco ; Tebaldi, Matteo ; Campo, Gianluca ; Gambetti, Stefania ; Bristot, Laura ; Monti, Monia ; Parrinello, Giovanni ; Ferrari, Roberto

JACC. Cardiovascular interventions, 2012-03, Vol.5 (3), p.268-277 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
3
Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY)
Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY)

Valgimigli, Marco ; Borghesi, Marco ; Tebaldi, Matteo ; Vranckx, Pascal ; Parrinello, Giovanni ; Ferrari, Roberto

European heart journal, 2013-03, Vol.34 (12), p.909-919 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
4
Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY)
Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY)

Valgimigli, Marco ; Tebaldi, Matteo ; Borghesi, Marco ; Vranckx, Pascal ; Campo, Gianluca ; Tumscitz, Carlo ; Cangiano, Elisa ; Minarelli, Monica ; Scalone, Antonella ; Cavazza, Caterina ; Marchesini, Jlenia ; Parrinello, Giovanni

JACC. Cardiovascular interventions, 2014-01, Vol.7 (1), p.20-28 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
5
Genetic determinants of on-clopidogrel high platelet reactivity
Genetic determinants of on-clopidogrel high platelet reactivity
Material Type:
Artigo 		Adicionar ao Meu Espaço

Genetic determinants of on-clopidogrel high platelet reactivity

Campo, Gianluca ; Miccoli, Matteo ; Tebaldi, Matteo ; Marchesini, Jlenia ; Fileti, Luca ; Monti, Monia ; Valgimigli, Marco ; Ferrari, Roberto

Platelets (Edinburgh), 2011-09, Vol.22 (6), p.399-407 [Periódico revisado por pares]

England: Informa UK, Ltd

Texto completo disponível

Citações Citado por
6
Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention: Design and rationale for the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia study (PRODIGY)
Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention: Design and rationale for the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia study (PRODIGY)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention: Design and rationale for the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia study (PRODIGY)

VALGIMIGLI, Marco ; CAMPO, Gianluca ; CANGIANO, Elisa ; TEBALDI, Matteo ; MINARELLI, Monica ; ARCOZZI, Chiara ; SCALONE, Antonella ; FRANGIONE, Alice ; BORGHESI, Marco ; MARCHESINI, Jlenia ; PARRINELLO, Giovanni ; FERRARI, Roberto ; PERCOCO, Gianfranco ; MONTI, Monia ; FERRARI, Fabrizio ; TUMSCITZ, Carlo ; ZUFFI, Andrea ; COLOMBO, Federico ; KUBBAJEH, Moh'd ; CAVAZZA, Caterina

The American heart journal, 2010-11, Vol.160 (5), p.804-811 [Periódico revisado por pares]

New York, NY: Mosby

Texto completo disponível

Citações Citado por
7
DETERMINATION OF THE URINARY NEUTROPHIL GELATINASE–ASSOCIATED LIPOCALIN AS AN EARLY MARKER OF CONTRAST INDUCED ACUTE KIDNEY INJURY AFTER CORONARY CATHETERIZATION
DETERMINATION OF THE URINARY NEUTROPHIL GELATINASE–ASSOCIATED LIPOCALIN AS AN EARLY MARKER OF CONTRAST INDUCED ACUTE KIDNEY INJURY AFTER CORONARY CATHETERIZATION
Material Type:
Artigo 		Adicionar ao Meu Espaço

DETERMINATION OF THE URINARY NEUTROPHIL GELATINASE–ASSOCIATED LIPOCALIN AS AN EARLY MARKER OF CONTRAST INDUCED ACUTE KIDNEY INJURY AFTER CORONARY CATHETERIZATION

Tebaldi, Matteo ; Valgimigli, Marco ; Campo, Gianluca ; Gambetti, Stefania ; Bristot, Laura ; Monti, Monia ; Ferrari, Roberto

Journal of the American College of Cardiology, 2013-03, Vol.61 (10), p.E1720-E1720 [Periódico revisado por pares]

New York: Elsevier Inc

Texto completo disponível

Citações Citado por
8
Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention
Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention

Valgimigli, Marco, MD, PhD ; Campo, Gianluca, MD ; Percoco, Gianfranco, MD ; Monti, Monia, BSc ; Ferrari, Fabrizio, MD ; Tumscitz, Carlo, MD ; Zuffi, Andrea, MD ; Colombo, Federico, MD ; Kubbajeh, Moh'd, MD ; Cavazza, Caterina, MD ; Cangiano, Elisa, MD ; Tebaldi, Matteo, MD ; Minarelli, Monica, MD ; Arcozzi, Chiara, MD ; Scalone, Antonella, MD ; Frangione, Alice, MD ; Borghesi, Marco, MD ; Marchesini, Jlenia, MD ; Parrinello, Giovanni, PhD ; Ferrari, Roberto, MD, PhD

The American heart journal, 2010, Vol.160 (5), p.804-811 [Periódico revisado por pares]

Mosby, Inc

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2010  (1)
  2. 2010Até2010  (2)
  3. 2011Até2011  (1)
  4. 2012Até2013  (4)
  5. Após 2013  (1)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.